Marimed CFO exercises 49,995 RSUs, holds 277,485 shares

Marimed Inc. Chief Financial Officer Mario Pinho reported the vesting and exercise of 49,995 Restricted Stock Units, converting on a one-for-one basis into the same number of common shares at $0.00 per share on January 15, 2026.

Rhea-AI Filing Summary

Marimed Inc. Chief Financial Officer Mario Pinho reported the vesting and exercise of 49,995 Restricted Stock Units, converting on a one-for-one basis into the same number of common shares at $0.00 per share on January 15, 2026. The issuer withheld 17,324 shares of common stock to satisfy tax withholding obligations related to this vesting. Following these transactions, Pinho directly holds 277,485 shares of Marimed common stock. The remaining RSUs from this July 15, 2024 grant are scheduled to vest in three equal installments on July 15, 2026, January 15, 2027 and July 15, 2027.

Insights

Equity compensation analyst

Routine RSU vesting and tax withholding by MariMed’s CFO.

MariMed’s Chief Financial Officer, Mario Pinho, reported the vesting of 49,995 restricted stock units on January 15, 2026, which converted one-for-one into common shares at an exercise price of $0. This is standard for RSUs, which typically convert without a cash payment when vesting conditions are met.

To cover tax obligations from this vesting, the issuer withheld 17,324 common shares at $0.096 per share, a common practice instead of using cash. After these events, Pinho directly holds 277,485 common shares and 149,985 RSUs that will continue to vest in three installments on July 15, 2026, January 15, 2027, and July 15, 2027. These are typical administrative equity-compensation transactions, with no clear signal of a discretionary open-market sale.

Insider Trade Summary

49,995 shares exercised/converted

Exercise 3 txns

Insider Pinho Mario

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	49,995	$0.00	$0.00
Exercise	Common stock	49,995	$0.00	$0.00
Exercise Price or Tax Liability	Common stock	17,324	$0.096	$2K

Holdings After Transaction: Restricted Stock Units (RSU) — 149,985 contracts (Direct); Common stock — 277,485 shares (Direct)

Footnotes (3)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
3. F3. The RSUs were granted on July 15, 2024; the remaining RSUs under this grant will vest in three equal installments, on each of July 15, 2026, January 15, 2027 and July 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

RSUs exercised: 49,995 shares Shares withheld for taxes: 17,324 shares Tax withholding price: $0.0960 per share +1 more

4 metrics

RSUs exercised 49,995 shares Restricted Stock Units converting into common stock on January 15, 2026

Shares withheld for taxes 17,324 shares Common stock withheld to satisfy tax obligations upon RSU vesting

Tax withholding price $0.0960 per share Per-share value used for tax-withholding shares

Post-transaction common shares held 277,485 shares Direct common stock holdings after the reported Form 4 transactions

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, derivative security

3 terms

Restricted Stock Units (RSU) financial

"Reported vesting and conversion of 49,995 Restricted Stock Units (RSU) into common stock"

tax withholding obligations financial

"Shares were withheld by the issuer to satisfy tax withholding obligations upon RSU vesting"

derivative security financial

"Transaction code M reflects exercise or conversion of a derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marimed (MRMD) report for its CFO?

Marimed (MRMD) disclosed that its CFO, Mario Pinho, had 49,995 Restricted Stock Units vest and convert into common stock on January 15, 2026. These RSUs converted one-for-one into shares, reflecting equity-based compensation rather than an open-market stock purchase or sale.

How many Marimed (MRMD) shares does CFO Mario Pinho now hold?

After the reported RSU vesting and tax withholding, CFO Mario Pinho directly holds 277,485 shares of Marimed common stock. This post-transaction holding reflects his updated equity position as reported in the insider filing’s canonical holdings data.

How many shares were withheld for taxes in the Marimed (MRMD) Form 4?

The filing shows 17,324 common shares were disposed of to cover tax withholding obligations associated with the RSU vesting. These shares were valued at $0.0960 per share for tax purposes, consistent with the transaction’s tax-withholding designation.

What is the vesting schedule for Mario Pinho's remaining RSUs at Marimed (MRMD)?

The remaining RSUs from Mario Pinho’s July 15, 2024 grant will vest in three equal installments. The scheduled vesting dates are July 15, 2026, January 15, 2027, and July 15, 2027, subject to the terms of his award agreement with Marimed.

Does the Marimed (MRMD) Form 4 show an open-market sale by the CFO?

The Form 4 does not report an open-market sale by the CFO. It records RSU vesting and a tax-withholding disposition, where 17,324 shares were delivered to the issuer for taxes, rather than a discretionary sale on the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/15/2026 - 04:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinho Mario

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MA 02062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	01/15/2026		M		49,995	A	$0(1)	294,809	D
Common stock	01/15/2026		F		17,324(2)	D	$0.096	277,485	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	01/15/2026		M			49,995	(3)	(3)	Common Stock, par value $.001 per share	49,995	$0	149,985	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on July 15, 2024; the remaining RSUs under this grant will vest in three equal installments, on each of July 15, 2026, January 15, 2027 and July 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Mario Pinho	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.